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Summary We report a patient who exhibited two paraneoplastic skin disorders, acrokeratosis paraneoplastica
and acquired ichthyosis, in association with Hodgkin disease. Treatment of the Hodgkin’s disease 
resulted in rapid improvement of both skin disorders, confirming a causal relationship. The 
simultaneous presence of two paraneoplastic skin disorders suggests a common pathogenetic 
factor. Transforming growth factor a, produced by tumour cells, may play a part in the 
aetiopathogenesis of hyperproliferative paraneoplastic skin conditions.
Acrokeratosis paraneoplastica was first described by 
Bazex in 1965,1 and is a rare but distinctive paraneo­
plastic dermatosis. It is associated with malignancies of 
the upper respiratory or digestive tract, or with cervical 
or mediastinal lymph node métastasés from distant 
occult neoplasms. Clinically, the syndrome evolves in 
three stages. The first stage is characterized by 
erythema and psoriasiform scaling on the fingers and 
toes, which soon spreads to the bridge of the nose and to 
the helices of the ears. Nail changes are frequent. In the 
second stage, a violaceous keratoderma of the palms 
and soles develops, and the facial lesions spread to the 
pinnae and cheeks. In the third stage, the eruption 
extends locally and begins to involve the legs, knees, 
thighs, arms, trunk and scalp. The dermatosis may 
antedate the diagnosis of malignancy or appear after 
its identification. In the most typical cases, the neo­
plasm begins to produce its first symptoms when the 
skin lesions have progressed to the second stage. 
Almost all the tumours associated with acrokeratosis 
paraneoplastica are squamous cell carcinomas. Excep­
tions include adenocarcinomas of the lung,6 oesopha­
gus,7 stomach8 and uterus and anaplastic small cell 
carcinoma of the lung.10,11
Associated features of acrokeratosis paraneoplastica 
include pruritus, vésiculation, sterile paronychia, 
hyperpigmentation, hypopigmentation, bullous lesions 
and carpal tunnel syndrome.12-14 An association with 
other cutaneous markèrs of malignancy has been 
reported in three patients, all of whom had acquired 
ichthyosis.8,13,14
Acquired ichthyosis is a manifestation of lymphopro- 
liferative and non-Iymphoproliferative malignancies.1
It has also been reported in essential fatty acid defi­
ciency,1 leprosy,17 renal disease with defects in proline 
metabolism,18 hyperparathyroidism,19 sarcoidosis, 
systemic lupus erythematosus,21,22 and after the 
administration of cholesterol-lowering drugs.
We report a patient with Hodgkin's disease who 
developed acrokeratosis paraneoplastica and acquired 
ichthyosis, an association which, as far as we are 
aware, has not been reported previously.
Case report
A 4 3-year-old man was referred with a 12-month 
history of a pruritic, scaly eruption which had started 
on the fingers and toes, and had subsequently spread to 
the nose, cheeks, ears and soles of the feet, and 
eventually to the scalp, trunk and limbs. Physical 
examination revealed brownish scales on the ears and 
cheeks, with psoriasiform scaling over the bridge of the 
nose, nasolabial folds and scalp. The soles of the feet 
showed a diffuse keratoderma, and the nails showed 
subungual hyperkeratosis, onychodystrophy and ony­
cholysis (Fig. la). All these findings were consistent 
with acrokeratosis paraneoplastica. In addition, a scaly 
rash was present on the trunk and limbs (Fig. 2a). 
Histopathological examination of a skin biopsy from 
the lower leg revealed hyperkeratosis and acanthosis, 
with a reduced or absent granular cell layer. The 
appearance was consistent with ichthyosis vulgaris.
Investigations revealed that he was anaemic and 
hypothyroid. The erythrocyte sedimentation rate was 
elevated at 110 mm in the first hour. Computerized 
tomographic examination revealed multiple enlarged
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Figure 1. (a) The nail changes of subungual 
hyperkeratosis, onychodystrophy and 
onycholysis, before treatment, (b) The nail 
changes have resolved after chemotherapy.
lymph nodes and multiple tumours (the largest with a 
diameter of 7 cm) in the abdomen, but no abnormalities 
in the chest. Echography of the thyroid gland was 
consistent with hypoplasia. Examination of a sternal 
marrow aspirate showed increased erythropoiesis and 
thrombopoiesis. Histology of a temporal artery biopsy 
was normal. An abdominal mass was biopsied, and the 
histology was consistent with Hodgkin’s disease. As the 
malignancy was localized beneath the diaphragm, a 
diagnosis of stage 2b Hodgkin’s disease was made.
Chemotherapy was started with a combination 
of mitoxine, vincristine, natulan and prednisone. 
The hypothyroidism was treated with thyroxine, 
and iron supplements were given to correct the 
anaemia.
On review 2 months later, after three courses 
of chemotherapy, the skin changes had improved, 
and both the acrokeratosis paraneoplastica and 
acquired ichthyosis had virtually resolved (Figs lb 
and 2b).
Figure 2. (a) Ichthyosiform scaling of the 
lower leg before treatment, (b) The 
appearance of the lower leg has reverted to 
normal after chemotherapy.
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Discussion
Our patient demonstrates the simultaneous presence of 
two cutaneous markers of malignancy, acrokeratosis 
paraneoplastica and acquired ichthyosis, in association 
with Hodgkin’s disease. Rapid improvement of both the 
paraneoplastic dermatoses was achieved by treatment 
of the underlying lymphoma, confirming a causal 
relationship. The simultaneous occurrence of acro­
keratosis paraneoplastica and acquired ichthyosis has 
been observed previously.8,13,14 However, the associa­
tion of acrokeratosis paraneoplastica with Hodgkin's 
disease has not been described. Acquired ichthyosis has 
been reported as a cutaneous marker for underlying
■
lymphoproliferative disorders, especially Hodgkin’s 
disease,24' 28 and is clinically and histologically similar 
to the genetically determined ichthyoses, especially 
autosomal dominant ichthyosis vulgaris29 Both 
acrokeratosis paraneoplastica and acquired ichthyosis 
parallel the neoplasia in its evolution, resolving with 
appropriate treatment and recurring with relapse. 
Hence, treatment of the underlying malignancy is the 
most appropriate therapy. However, when the under­
lying neoplasm is incurable, cutaneous lesions may 
respond to topical or systemic corticosteroids or
in
retinoids. The pathogenesis of cutaneous paraneo­
plastic disorders is uncertain. Expression of transform­
ing growth factor alpha (TGF-a) has been found in 
tumour tissue from a patient with gastric cancer and 
acanthosis nigricans maligna.31 Increased expression of 
the receptor for epidermal growth factor (EGF), the 
common ligand for TGF-ct; and EGF, has been demon­
strated by Ellis et a l ,u  in the affected skin of acanthosis 
nigricans maligna. After excision of the underlying 
malignancy, the distribution of the EGF/TGF-a receptor 
reverted to its usual predominantly basal location. 
Coincident with this change, urinary TGF-o; was also 
decreased. TGF-a is highly mitogenic for keratino- 
cytes,33 and these findings suggest that factors released 
by the tumour may play an important part in the 
pathogenesis of hyperproliferative cutaneous paraneo­
plastic syndromes.
Acrokeratosis paraneoplastica and acquired ichthyo­
sis have been regarded as separate entities, with 
acrokeratosis paraneoplastica a cutaneous marker for 
squamous cell and adenocarcinomas, and acquired 
ichthyosis being related particularly to lympho­
proliferative disorders. The simultaneous presence of 
both conditions as paraneoplastic manifestations of 
Hodgkin's disease suggests a common pathogenetic 
mechanism.
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